Picard Medical is trading 10.6% lower at $3.86 on October 2, 2026; no clear company-specific announcement has explained the decline. - Available company-news listings show no new October 2 catalyst. - Healthcare and pharmaceutical stocks were also moving lower, despite the broader market rising after weak jobs data eased rate concerns. - Sector weakness is relevant context, but available evidence does not establish a direct cause for Picard Medical’s decline.